Search research articles
Contact Us
Filters
Showing results (311-320 of 328) with videos related to
Page
of 33
Sort By:
Palliative & Supportive Care
|
April 22, 2025
Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review
Maria I Lapid, Sandeep R Pagali, Andrea L Randall, et al.
Bioorganic & Medicinal Chemistry
|
May 6, 2009
Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies
Herman D Lim, Enade P Istyastono, Andrea van de Stolpe, et al.
British Journal of Cancer
|
October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors
M Koczywas, P H Frankel, T W Synold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
S J Wong, T Karrison, D N Hayes, et al.
Journal of Echocardiography
|
June 24, 2026
Sex differences in echocardiographic left ventricular remodeling and clinical outcomes following transcatheter aortic valve implantation
Jocelyn Chai, Matthew Cheung, Joshua Yoon, et al.
The Lancet. Infectious Diseases
|
June 30, 2020
Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis
Abena S Amoah, Pytsje T Hoekstra, Miriam Casacuberta-Partal, et al.
Science Signaling
|
April 3, 2020
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis, Arisbel B Gondin, Andrea Kliewer, et al.
BJU International
|
November 19, 2016
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study
Amishi Y Shah, Jose A Karam, Gabriel G Malouf, et al.
ACS Pharmacology & Translational Science
|
January 19, 2023
Identification and Characterization of ML321: A Novel and Highly Selective D<sub>2</sub> Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity
R Benjamin Free, Ashley N Nilson, Noelia M Boldizsar, et al.
Kidney International
|
September 26, 2025
Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023
William E Smoyer, Barbara S Gillespie, Louise Oni, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 328) with videos related to
Sort By:
Page
of 33
Palliative & Supportive Care
|
April 22, 2025
Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review
Maria I Lapid, Sandeep R Pagali, Andrea L Randall, et al.
Bioorganic & Medicinal Chemistry
|
May 6, 2009
Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies
Herman D Lim, Enade P Istyastono, Andrea van de Stolpe, et al.
British Journal of Cancer
|
October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors
M Koczywas, P H Frankel, T W Synold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
S J Wong, T Karrison, D N Hayes, et al.
Journal of Echocardiography
|
June 24, 2026
Sex differences in echocardiographic left ventricular remodeling and clinical outcomes following transcatheter aortic valve implantation
Jocelyn Chai, Matthew Cheung, Joshua Yoon, et al.
The Lancet. Infectious Diseases
|
June 30, 2020
Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis
Abena S Amoah, Pytsje T Hoekstra, Miriam Casacuberta-Partal, et al.
Science Signaling
|
April 3, 2020
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis, Arisbel B Gondin, Andrea Kliewer, et al.
BJU International
|
November 19, 2016
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study
Amishi Y Shah, Jose A Karam, Gabriel G Malouf, et al.
ACS Pharmacology & Translational Science
|
January 19, 2023
Identification and Characterization of ML321: A Novel and Highly Selective D<sub>2</sub> Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity
R Benjamin Free, Ashley N Nilson, Noelia M Boldizsar, et al.
Kidney International
|
September 26, 2025
Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023
William E Smoyer, Barbara S Gillespie, Louise Oni, et al.
Page
of 33